Case Report
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Mar 16, 2022; 10(8): 2550-2558
Published online Mar 16, 2022. doi: 10.12998/wjcc.v10.i8.2550
Daptomycin and linezolid for severe methicillin-resistant Staphylococcus aureus psoas abscess and bacteremia: A case report and review of the literature
Xiao-Bing Hong, Ze-Lin Yu, Hong-Bo Fu, Ze-Hong Cai, Jie Chen
Xiao-Bing Hong, Ze-Lin Yu, Hong-Bo Fu, Department of Pharmacy, The Second Affiliated Hospital of Shantou University of Medical College, Shantou 515041, Guangdong Province, China
Ze-Hong Cai, Department of Pharmacology, Shantou University Medical College, Shantou 515041, Guangdong Province, China
Jie Chen, Department of Pharmacy, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510080, Guangdong Province, China
Author contributions: Hong XB and Yu ZL were responsible for the article writing and data analysis; Hong XB and Yu ZL contributed equally to this study, and considered as co-first authors; Hong XB was the chief investigator and responsible for the data analysis; Chen J, Fu HB and Cai ZH were responsible for modifying the article; all authors contributed to the writing of the final manuscript.
Supported by Shantou Medical and Health Science and Technology Program, No. SFK [2020] 66-23.
Informed consent statement: We obtained written informed consent from the patient, according to the rules of the Clinical Research Ethics Committee of the First Affiliated Hospital of Sun Yat-Sen University.
Conflict-of-interest statement: The authors declare that they have no competing interests.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Jie Chen, MD, Associate Chief Pharmacist, Department of Pharmacy, The First Affiliated Hospital, Sun Yat-Sen University, No. 58 Second Zhongshan Road, Yuexiu District, Guangzhou 510080, Guangdong Province, China. chenjiezs@163.com
Received: August 31, 2021
Peer-review started: August 31, 2021
First decision: November 17, 2021
Revised: November 18, 2021
Accepted: January 27, 2022
Article in press: January 27, 2022
Published online: March 16, 2022
Processing time: 191 Days and 9.8 Hours
Core Tip

Core Tip: We analyzed a case of severe methicillin-resistant Staphylococcus aureus (MRSA) bacteremia who failed to respond to first line treatment using vancomycin. We believe that our study makes a significant contribution to the literature because it indicates that daptomycin combined with linezolid is an effective remedy for bacteremia caused by MRSA with pulmonary complications.